Xiaowu Li
- Molecular Biology
- Oncology
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Hepatology top 5%
- Co-authors
- Yin ZongyiJoseph A. RegeziAmha AtakilitDongmin DangDaniel M. RamosBrian L. SchmidtRichard C. JordanShuguang Wang
- Topics
- Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers)Hepatocellular Carcinoma Treatment and Prognosis (4 papers)Liver Disease Diagnosis and Treatment (4 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBiochemical and Biophysical Research Communications
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaowu Li
25 papers receiving 612 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 258
- Oncology 198
- Cancer Research 173
- Pulmonary and Respiratory Medicine 140
- Hepatology 137
Countries citing papers authored by Xiaowu Li
This map shows the geographic impact of Xiaowu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowu Li more than expected).
Fields of papers citing papers by Xiaowu Li
This network shows the impact of papers produced by Xiaowu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowu Li. The network helps show where Xiaowu Li may publish in the future.
Co-authorship network of co-authors of Xiaowu Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowu Li. A scholar is included among the top collaborators of Xiaowu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowu Li. Xiaowu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 23 | |
| 4 | 6 | |
| 5 | 21 | |
| 6 | 1 | |
| 7 | 187 | |
| 8 | 16 | |
| 9 | 22 | |
| 10 | 7 | |
| 11 | 17 | |
| 12 | 54 | |
| 13 | 6 | |
| 14 | CD44, CD133 and TF correlate with formation of portal vein tumor thrombus and poor prognosis in patients with hepatocellular carcinoma | 3 |
| 15 | 32 | |
| 16 | 10 | |
| 17 | 41 | |
| 18 | 11 | |
| 19 | 110 | |
| 20 | 1 |
About Xiaowu Li
Xiaowu Li is a scholar working on Hepatology, Immunology and Allergy and Biotechnology, having authored 26 papers that have together received 618 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). The work is most often cited by research in Immunology and Allergy (109 citations), Hepatology (137 citations) and Cancer Research (173 citations). Xiaowu Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yin Zongyi, Joseph A. Regezi, Amha Atakilit, Dongmin Dang, Daniel M. Ramos, Brian L. Schmidt, Richard C. Jordan, Shuguang Wang, Jianwei Li and Wei Liu. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.